BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11324683)

  • 1. HLA transgenic mice as models of human autoimmune diseases.
    Das P; Abraham R; David C
    Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class II transgenic mice mimic human inflammatory diseases.
    Mangalam AK; Rajagopalan G; Taneja V; David CS
    Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized animal models for autoimmune diseases.
    Gregersen JW; Holmes S; Fugger L
    Tissue Antigens; 2004 May; 63(5):383-94. PubMed ID: 15104670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA transgenic mice as humanized mouse models of disease and immunity.
    Taneja V; David CS
    J Clin Invest; 1998 Mar; 101(5):921-6. PubMed ID: 9486959
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA class II transgenic mice as models of human diseases.
    Taneja V; David CS
    Immunol Rev; 1999 Jun; 169():67-79. PubMed ID: 10450509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polychondritis.
    Bradley DS; Das P; Griffiths MM; Luthra HS; David CS
    J Immunol; 1998 Nov; 161(9):5046-53. PubMed ID: 9794442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?
    Zanelli E; Gonzalez-Gay MA; David CS
    Immunol Today; 1995 Jun; 16(6):274-8. PubMed ID: 7544977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].
    Nishimura Y
    Nihon Rinsho; 1997 Jun; 55(6):1384-96. PubMed ID: 9200922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease.
    Gregersen PK
    Lab Invest; 1989 Jul; 61(1):5-19. PubMed ID: 2664347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
    Mangalam A; Rodriguez M; David C
    Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized transgenic mice expressing HLA DR4-DQ3 haplotype: reconstitution of phenotype and HLA-restricted T-cell responses.
    Chen Z; de Kauwe AL; Keech C; Wijburg O; Simpfendorfer K; Alexander WS; McCluskey J
    Tissue Antigens; 2006 Sep; 68(3):210-9. PubMed ID: 16948641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition.
    Zanelli E; Krco CJ; David CS
    J Immunol; 1997 Apr; 158(7):3545-51. PubMed ID: 9120317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of HLA DR3/DQ2 transgenic mice: a potential humanized animal model for autoimmune disease studies.
    Chen D; Ueda R; Harding F; Patil N; Mao Y; Kurahara C; Platenburg G; Huang M
    Eur J Immunol; 2003 Jan; 33(1):172-82. PubMed ID: 12594846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DQB1 alleles may influence the surface expression of DQ molecules in lymphomononuclear cells of type 1 diabetes mellitus patients.
    Fernandes AP; Foss MC; Donadi EA
    Scand J Immunol; 2004 Mar; 59(3):305-9. PubMed ID: 15030582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells.
    Moustakas AK; Papadopoulos GK
    Am J Med Genet; 2002 May; 115(1):37-47. PubMed ID: 12116175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
    Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
    Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases.
    Ou D; Mitchell LA; Tingle AJ
    J Rheumatol; 1997 Feb; 24(2):253-61. PubMed ID: 9034980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Co-operative Specificity Theory: phenotypic protection from T1D by certain HLA Class II DRB1 and DQ alleles identifies the absence of co-operation between the respective DR and DQ molecules eventuating in no T1D-predisposition.
    Temajo NO; Howard N
    Autoimmun Rev; 2009 Mar; 8(5):364-8. PubMed ID: 19068242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of T cell activation by blockade of MHC class II molecules.
    Adorini L; Valli A; Guéry JC
    Semin Immunol; 1991 Jul; 3(4):231-6. PubMed ID: 1932705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II major histocompatibility complex and organ specific autoimmunity in man.
    Foulis AK
    J Pathol; 1986 Sep; 150(1):5-11. PubMed ID: 2946837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.